#India #Life Sciences #Global Health #Hyderabad #Telangana

Telangana's Ambitious Next-Gen Life Sciences Policy 2026-30

On January 22, 2026, at the World Economic Forum in Davos, the government of Telangana, India, introduced its Next-Gen Life Sciences Policy for the period 2026-30. This strategic initiative aims to position the state among the top five global life sciences hubs by 2030. The policy focuses on a significant transition from scale-centric manufacturing to an innovation-driven value proposition which is critical for the region's future role in global health.

Strategic Goals and Investments

Telangana's new policy reflects an intent to contribute meaningfully to the global healthcare landscape. The state targets an investment of $25 billion and the creation of 500,000 high-quality jobs, alongside deeper integration into global life science value chains. This ambitious plan emphasizes the necessity of enhancing the region's research and development capabilities, moving away from being merely a manufacturing base.

In doing so, Telangana is already seeing expanding partnerships with numerous global scientific organizations. Well-known companies such as Amgen, Sanofi, Bristol Myers Squibb, and Lilly have established or expanded their research and development centers in Hyderabad, all of which underline the state's commitment to fostering scientific talent and an innovation-friendly ecosystem.

Focus on Innovation and Advanced Therapeutics

The policy distinctly reorients Telangana's focus towards pioneering research and advanced manufacturing platforms. By prioritizing next-generation modalities such as cell and gene therapies, peptides, and precision fermentation, Telangana is set to enhance its interoperability within the global life sciences framework. The initiative is expected to support a comprehensive ecosystem encompassing clinical research, pharmaceutical services, diagnostics, medical electronics, and digital health, thereby positioning Telangana as a go-to destination for global life science entities.

A comprehensive infrastructure supports this policy, including projects like the Green Pharma City and ten Pharma Villages, while further enhancing the Genome Valley and Medical Devices Park. Complementing this robust infrastructure is a dedicated Life Sciences Innovation Fund, which can provide up to ₹10 billion (around $100 million) to spur early-stage growth and deep-tech ventures by attracting both private and institutional investments.

Educational Excellence and Research

The establishment of the Telangana School of Life Sciences is also a key development. Designed to be an institution of global excellence, this university will focus on research, education, and the nurturing of future talent in the life sciences sector.

For two decades, Telangana has evolved from being merely a production hub to becoming an integrated life sciences center that encompasses foundational research, clinical development, advanced manufacturing, and global engagement. The state hosts over 2,000 life sciences firms and is known for having a high concentration of FDA-approved pharmaceutical facilities, supplying one-third of the global vaccine demand and acting as a trusted partner in pharmaceuticals for leading worldwide firms.

By adopting a life sciences policy that champions innovation while solidifying its position in global supply chains, Telangana demonstrates its readiness to be at the forefront of the global health revolution. The unveiling of this policy at an international forum like Davos signifies the state's belief that collaborative international efforts, global capital, and unified innovative agendas will drive the next growth phases in the life sciences sector. As such, Telangana is not only preparing to strengthen its healthcare contributions but also setting a standard for others aiming to enhance their roles in the global health ecosystem.

Conclusion

Telangana's Next-Gen Life Sciences Policy 2026-30 marks a transformative step in the state's ambition to become a global leader in life sciences. Through significant investments, a focus on innovation, and the development of a supportive ecosystem, Telangana is poised to shape the future of healthcare advancements on the international stage.